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Abstract 
Increased incidence of protothecal mastitis has been recorded in several countries in the past ten years. The main goal of 
this article is to draw the attention of scientific and professional community to the emerging issue of mammary protothecosis. 
The article collates currently known facts about infection reservoirs, predisposing factors for the development of mastitis, clinical 
manifestations of the disease, and potential transmission routes within the herd as well as the measures for control and 
eradication. We would like to point out that identification of protothecal mastitis on a dairy farm is associated with a range of 
problems. Early detection of infected animals can be difficult because of predominantly subclinical course of early-stage 
infection, which easily spreads between cows via the milking system. Spontaneous recovery has not been recorded and infected 
cows typically develop chronic mastitis with granulomatous infiltration and progressive loss of functional parenchyma of the 
mammary gland. Substantial economic losses and health damages associated with mammary protothecosis strongly emphasise 
the need for developing effective prevention strategies aimed at control of the infection. 
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Introduction 
The algae from the genus Prototheca are closely 
related to the Chlorella sp., green algae from the same 
family of Chlorellaceae; however, Prototheca has lost 
its ability to synthesise chlorophyll and adopted  
a heterotrophic mode of nutrition (12, 16, 26). The 
genus Prototheca encompasses six generally accepted 
species: P. stagnora, P. ulmea, P. blaschkeae,  
P. wickerhamii, P. zopfii, and P. cutis sp. nov. (8, 12, 
30). The species P. blaschkeae, P. wickerhamii,  
P. zopfii, and P. cutis are considered causal agents of 
local human and/or animal infections (18, 21, 28, 30, 
31). Systemic infections associated with these 
organisms are relatively rare. 
According to its assimilation patterns P. zopfii has 
been subdivided into three biotypes or variants: 1, 2, 
and 3. Biotype 2 is characterised by delayed 
assimilation of galactose and increased assimilation of 
amino acids in comparison to biotype 1, whilst the 
strains of biotype 3 are incapable of glycerol 
assimilation (27). P. zopfii biotype 2 has been 
established to be the major causative agent of mastitis 
in dairy cows (3, 9, 14, 22, 23, 29). Genotype 1 is 
considered to be non-pathogenic (12). Roesler et al. 
(28) showed that the three biotypes clearly differ in 
both the small-subunit (18S) rRNA gene and cellular 
fatty acid composition. It has been proven that partial 
sequences (1442 bp) of the 18S rRNA genes differ 
between the strains of the three biotypes, and all the 
strains of a certain biotype belong to the same species. 
The sequences of biotype 3 differed from the others 
and had a sequence similarity of 98.1%. Also, there 
was a difference between the sequences of biotype 2 
and biotype 1, with a similarity of 99.4%. Thus, the 
phylogenetic distance is the largest between strains of 
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P. zopfii biotype 3 and the biotypes 1 and 2 (28). Later 
on, two novel genotypes 1 and 2 were proposed, 
whereas biotype 3 was categorised as the new species - 
Prototheca blaschkeae sp. nov. (22, 28).  
P. zopfii was first identified as a causative agent of 
bovine mastitis in Germany in 1952 (17). So far,  
P. zopfii has been isolated worldwide from milk of 
cows with clinical and subclinical mastitis (1, 2, 6, 17). 
In Serbia, protothecal mastitis has been first diagnosed 
in 2006 on a Holstein-Friesian dairy farm in Vojvodina 
(20). Isolation of P. blaschkeae and P. wickerhamii has 
also been reported; however, the organisms are 
considered rare causal agents of bovine mastitis (7,  
14, 29). 
Throughout the past few years, substantial 
increase in incidence of P. zopfii mastitis has been 
reported all over the world (3, 9, 10, 16, 26, 29, 31). 
Since 2006, P. zopfii has been isolated from milk on 
four dairy farms in the regions of Vojvodina and 
Central Serbia; however, its much wider prevalence is 
suspected in some regions of Serbia even though it has 
not yet been isolated. The objective of this article is to 
draw the attention of scientific and professional 
community to the growing problem of P. zopfii mastitis 
and its clinical, epizootiological, and diagnostic aspects 
as well as potential human health implications.  
Common habitats of P. zopfii and the potential 
source of infection for cows  
P. zopfii is widely distributed in the nature. Humid 
areas, particularly these containing manure and 
decomposing plant material, are its natural habitat (26). 
As the diet of dairy cattle is based on feed of plant 
origin, the algae may be a transient flora in the 
gastrointestinal tract of cows and as such are excreted 
intact (17). As a consequence of recent global climate 
changes, high temperatures, often combined with high 
humidity, enhance the multiplication of the algae in the 
environment (4, 7, 13, 31). P. zopfii is a unicellular alga 
that reproduces asexually by formation of 2-16 
daughter cells (endospores) inside the mother cell 
(sporangia) (25). The rupture of the sporangia releases 
the endospores that start the new cycle of their 
development into mature sporangia (Fig. 1). The 
reproduction cycle takes place at higher temperatures, 
with the lowest temperature limit estimated at about 
25C (10, 26).  
Along with the majority of other mastitic agents, 
P. zopfii is assigned to a group of environment-borne 
pathogens. Identification of potential infection sources 
on the farm is useful in view of implementation of 
relevant preventive measures; however, the real source 
of infection often remains unknown (13). At a dairy 
farm with protothecal mastitis, Osumi et al. (23) 
isolated P. zopfii from drinking water, bovine faeces, 
sewage water, and the milk of infected cows. The 
analysis using genotype-specific PCR assays and 
restriction fragment length polymorphism (RFLP) test 
revealed P. zopfii genotype 2 in all isolates from cow 
milk (n = 67). Still, out of 32 isolates collected from the 
environment as many as 29 were identified as genotype 1, 
whereas only three isolates belonged to genotype 2 
(23). Specific reservoir of P. zopfii in the environment 
has not been identified. 
 
 
Fig. 1. Scanning electron microscopy of P. zopfii isolates from cow’s 
milk: a – sporangia of Prototheca zopfii (7-16 µm); b and  
c – comparison of the size of P.zopfii spores with the cells of 
Staphylococcus sp. (up to 1 µm) (Milanov D., Scientific Veterinary 
Institute „Novi Sad“; scanning electron microscopy: Prof Dr 
Bokorov M., Faculty of Sciences, University of Novi Sad) 
  
Infected cows cannot be excluded as the possible 
sources of infection for other animals. P. zopfii was 
isolated from milking machine liners and milking cups 
(16). The organism can be transferred from infected 
cows to other animals in the same way as any other 
agent of contagious mastitis (2).  
Predisposing factors for the development of P. zopfii 
mastitis 
P. zopfii is commonly detected in cow faeces and 
in a range of environmental sources even on farms with 
no history of protothecal mastitis (2, 17). Ubiquitous 
distribution of the organism in the nature and relatively 
low pathogenic potential of P. zopfii underline the role 
of predisposing factors in the development of mastitis. 
Identification of relevant risk factors is of major 
importance in the control of the disease; however, 
causal relationships between various factors in each 
individual case are still difficult to establish. Poor 
hygiene practices, excessive antibiotic use, and 
inadequate milking hygiene are most commonly 
considered the major risk factors for mastitis 
development (10, 13, 17, 24, 26, 31).  
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Pieper et al. (24) have conducted extensive 
research aimed at identifying cow- and herd-level risk 
factors for the occurrence of Prototheca mastitis. The 
research encompassed 23 Holstein-Friesian farms in 
Ontario (Canada). Prototheca spp. was isolated from 
64 milk samples from cows originating from 18 farms 
with an average prevalence of 5.1% (range 0.0%–
12.5%). The authors believe that the actual prevalence 
of Prototheca spp. in positive herds and animals was 
even higher than the one determined in this study, 
because cows that were dry at the time of the 
investigation were not tested. Moreover, intermittent 
shedding of the algae in milk may prevent detection of 
the agent during one single testing or examination of 
lactating cows. Pieper et al. (24) established that 
unsanitary or repeated intramammary infusions and 
antibiotic treatment can contribute to the development 
of Prototheca infection of the mammary gland. 
Similarly to other pathogens manifesting natural 
resistance to antibiotics, inadequate intramammary 
administration of antibiotics (contaminated applicator 
or inadequate teat disinfection before administration) is 
an important risk factor for direct introduction of the 
organism into the mammary gland. Excessive usage of 
antibiotics and consequent elimination of the 
competitive natural udder flora can give rise to the 
development of algal infections. Interestingly, specific 
farm management practices or milking hygiene 
deficiencies were not identified as risk factors for 
occurrence of Prototheca mastitis in the 
aforementioned study (24). 
Development of mammary infection with P. zopfii  
Intramammary protothecosis always develops as 
an ascending infection (15). The cows are susceptible 
to infection disregarding the age and lactation stage. 
Protothecal mastitis frequently affects primiparous 
cows, but can also develop during the dry periods. 
Cows in early lactation are particularly susceptible, 
which is due to energy imbalance and physiologically 
reduced immunity (13, 20, 31). An open teat sphincter 
as well as some small teat lesions caused by milking 
equipment constitute a potential portal of entry of the 
infection (11). 
In the dry period, especially immediately before 
and after parturition, the mammary gland is highly 
susceptible to infections caused by environmental 
microorganisms (5). Thus, mastitis control programmes 
usually include intramammary application of 
antibiotics which are to eliminate the existing 
infections and to prevent the potential new infections. 
However, not only may the expected effects be absent 
(5), but such intrammamary administration may 
involve the risk of iatrogenic contamination and direct 
entrance of Prototheca or other pathogens into the 
mammary gland.  
 
Clinical manifestations of P. zopfii mastitis  
P. zopfii mastitis can occur as sporadic infection, 
but endemic forms have also been reported (13, 15, 20). 
The inflammatory process can affect individual 
quarters as well as the entire udder. At the outset, the 
infection is commonly asymptomatic. Contrary to 
infections caused by other mastitic pathogens, the 
initial mammary immune response to protothecal 
infection is very mild, and the somatic cell count (SCC) 
usually remains unchanged during the initial stages of 
the disease (31). In cows infected with P. zopfii, the 
SCC in quarter and composite milk samples can be 
lower than 100,000 cells/mL (24). The infection is 
commonly subclinical and is discovered only after 
significant increase of the SCC (8). If the composite 
milk sample is tested for the SCC, the infection of 
individual quarters can remain unnoticed. Even 
significant increase in the SCC can be missed in 
composite milk sample because of mixing (i.e. diluting) 
with milk from healthy quarters. Throughout the further 
course of the disease, the number of somatic cells 
increases from 500,000/mL (11) to even several 
millions (13, 31). The SCC value in milk originating 
from a cow with clinical protothecal mastitis can 
exceed 20 million/mL (17). 
Clinically manifested infections are associated 
with changes in the appearance and consistency of 
milk. It becomes watery, grayish in colour, with or 
without small flakes (Fig. 2). Udder pain and oedema 
can occur in some animals (17, 31). Absence of 
systemic infection manifestations has been commonly 
observed (14), whereas increased body temperature and 
appetite loss were rarely reported (31). 
 
Fig. 2. Appearance of a milk drop originating from cow with 
protothecal mastitis (upper) compared with milk of healthy 
cow (lower) on blood agar (Milanov D., Scientific Veterinary 
Institute „Novi Sad“) 
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Protothecal mastitis is not a self-limiting infection 
and does not cure spontaneously. The infection 
becomes chronic and P. zopfii persists inside the 
macrophages in the udder through several lactating and 
dry periods (13). In turn, milk production decreases 
while the SCC increases (4, 31, 32). Local immune 
response results in granulomatous proliferation and 
irreversible atrophy of functional parenchyma (13, 20, 
31). Histopathological examination of the mammary 
gland reveals the presence of P. zopfii organisms in the 
alveolar lumen, interstitium, neutrophils, and 
macrophages (17, 31). Our research conducted on the 
dairy farm in Serbia, where we first diagnosed P. zopfii 
mastitis in 2006, revealed pronounced enlargement and 
hard consistency (stiffness) of infected udders of 
diseased animals. In individual animals, chronic 
infection resulted in highly severe granulomatous 
proliferations which even caused rupture of udder skin 
due to over-stretching. Such situation on the farm is 
likely due to a range of previous misdiagnoses and 
consequent prolonged inadequate antibiotic treatments. 
So far, virulence factors of P. zopfii as well as the 
differences in pathogenic potential of various 
Prototheca species and genotypes have not been fully 
elucidated (12). Thus, the course and pathogenesis of 
protothecal diseases still remain unclear.   
Diagnosis of P. zopfii mastitis  
An accurate diagnosis of protothecal mastitis 
relies on isolation and identification of the agent (26, 
31). If protothecal mastitis has been established in the 
herd, immediate examination of milk from all cows is 
of crucial importance for detecting early and 
subclinical infections. Milk samples from individual 
quarters should be examined to avoid diagnostic 
failure. Namely, if only one quarter is infected, dilution 
with milk from healthy, uninfected quarters will 
decrease the pathogen count in composite milk sample 
below the limit of detection (24). Intermittent shedding 
the organism by infected cows calls for regular 
repeated testing (10, 24). Advanced stages of the 
disease are characterised by highly elevated numbers of 
algae in milk of infected cows, and laboratory 
diagnosis is quite simple to establish. 
P. zopfii grows readily on conventional laboratory 
media such as 5% sheep blood agar, and MacConkey 
and Sabouraud dextrose agars. Prototheca is a slow-
growing alga, thus requiring a two- to three-day 
incubation period on 5% sheep blood agar. After 48- 
72 h incubation on blood agar, Prototheca zopfii forms 
distinct small gray colonies of around 1 mm in 
diameter, without haemolysis. Colonies grown on 
MacConkey agar are extremely small. The growth of  
P. zopfii on Sabouraud dextrose agar can be observed 
after 24 h of incubation at 37C (Fig. 3a, left). The 
colonies are usually smaller as compared with those of 
Candida species, but after 48 h they are clearly visible, 
white to cream-coloured, 3-4 mm in diameter (Fig. 3a, 
right). P. zopfii grows at incubation temperatures 
between 25 and 37C. 
Isolation and identification of P. zopfii from cow 
milk has not yet been introduced into routine practice 
of many microbiology laboratories in Serbia. 
Moreover, the herd veterinarians are not well-
acquainted with the clinical and epizootiologic 
characteristics of protothecal mastitis. Dairy farms can 
suffer substantial economic losses due to ill-timed 
suspicion of Prototheca infection, and hence the lack of 
early and accurate aetiological diagnosis. Protothecal 
mastitis can result in culling of the entire herd as it was 
the case in 2006, at the aforementioned Holstein-
Friesian dairy farm in Serbia. During 2015, we found 
an endemic form of protothecal mastitis on a dairy farm 
in Serbia. More than 30 high-yielding dairy cows were 
culled from the herd, while microbiological 
examination revealed subclinical P. zopfii infection in 
12 more cows. Regrettably, throughout the preceding 
period of more than one year, milk samples from this 
farm had been regularly submitted for testing to the 
regional veterinary microbiology laboratory (because 
of history of positive California mastitis test) where  
P. zopfii had been misidentified as Candida spp.  
 
 
Fig. 3. Cultural and microscopic characteristics of P. zopfii isolates 
from cow’s milk. a – Prototheca zopfii colonies on Sabouraud 
dextrose agar after 24 h (left) and 48 h (right) of incubation at 37C; 
b – colonial appearance of Prototheca zopfii (light microscopy,  
200 x); c – Gram-negative empty sporangia and Gram-positive spores 
of Prototheca zopfii (light microscopy, 1000 x). Photo: Milanov D., 
Scientific Veterinary Institute „Novi Sad“ 
 
P. zopfii differs from Candida species by its 
colonial appearance, though comparison of these two 
microbial species commonly relies on their growth 
characteristics. We are of the opinion that the similarity 
applies only to more intensive growth on Sabouraud 
dextrose agar as compared with some other culture 
media for isolation of mastitic agents (5% sheep blood 
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agar or MacConkey agar). Low magnification of  
light microscopy revealed characteristic granulated 
appearance of P. zopfii colonies on Sabouraud dextrose 
agar (Fig. 3b), which has not been observed in yeast 
cultures in our practice so far. Gram-staining of the 
microscopic preparation clearly distinguished the algae 
from yeasts. The preparations revealed Gram-positive 
spores and Gram-negative sporangia (Fig. 3c). 
Morphological features, i.e. the structure of sporangia 
at different stages of sporulation process, are easily 
perceptible by examining a fresh drop of colonial 
suspension in one drop of Lugol’s solution, 
lactophenol, toluidine blue, or in preparations stained 
with methylene blue, malachite green, Congo red, or 
fuchsine (26). Once transferred into the liquid, P. zopfii 
disperses easily and uniformly, which is not typical for 
yeasts. A range of commercial biochemical tests such 
as API 20 C and ID32 systems are available for rapid 
differentiation of algae from yeasts (26). The main 
drawback of the standard method of isolation and 
identification of P. zopfii is its duration – it usually 
takes more than three days. Thus, molecular techniques 
(PCR) for prompt identification of Prototheca zopfii 
genotypes 2 directly from milk samples are available 
today (8, 9). It has been proven that PCR- and RFLP-
assays may distinguish between pathogenic and 
apathogenic strains of P. zopfii and between these and 
P. blaschkeae, a putative milk contaminant (22). 
Treatment of P. zopfii mastitis  
Prototheca mastitis is an incurable infection. In 
vitro, P. zopfii isolates from cow milk manifest 
susceptibility towards antifungal agents such as 
amphotericin B and nystatin, and even towards some 
antibiotics such as gentamicin, neomycin, and 
streptomycin. Wawron et al. (32) established resistance 
to clotrimazole, fluconazole, econazole, and flucytosine 
in all strains of P. zopfii (n = 27) isolated from the milk 
of cows from one herd in the north-eastern part of 
Poland. We found nystatin, ketoconazole and 
amphotericin B (88.9% and 0.0%, 51.9% and 22.2%, 
0.0% and 48.1% of susceptible and intermediate 
susceptible isolates respectively) as well as gentamicin 
(96.3%), kanamycin (92.6%), and polymyxin B 
(59.3%) to be effective against P. zopfii. However, in 
vitro susceptibility of Prototheca isolates does not 
correlate with the effectiveness of antifungal agents in 
vivo. Mastitis is commonly left untreated and infected 
animals should be removed into a separate group and 
milked as last until culled from the herd. 
Current research is aimed at the identification of 
immunogenic proteins of P. zopfii and the development 
of immunoprophylaxis. Due to the absence of effective 
treatment of prototheca infections, immunisation and 
immune therapy are of utmost importance. Protein 
extracts may be used to induce the host’s immune 
response. For example, Hsp70 protein is considered the 
major antigen of P. zopfii genotype 2, responsible for  
a strong pro-inflammatory response (12). Knowledge 
on the sequence of the Prototheca genome will enable 
the understanding of the pathways of infection and  
a specific immunisation based on recombinant proteins.  
Consumption of milk and dairy products from 
infected cows may pose a risk for human health 
Human health concerns exist to some degree with 
respect to consumption of pasteurised milk or dairy 
products. P. zopfii is resistant to pasteurisation, and its 
potential to cause human enteritis has been reported (3, 
12, 19). 
Concluding remarks 
Mastitis associated with P. zopfii cause substantial 
health and economic damage on dairy farms. Thus, 
efforts should be made to implement effective 
prevention strategies which would enable putting the 
disease under control. Good farm management 
practices, well-balanced nutrition of dairy cows, as well 
as adequate disinfection of milking equipment are the 
prerequisites for the accomplishment of this goal. 
Regular microbiological examination of milk samples 
from all cows is crucial for timely detection of the 
infection. The method of isolation and identification of 
P. zopfii has to be implemented into routine practice of 
laboratories involved in identification of mastitic 
agents. Furthermore, awareness of field veterinarians 
and their knowledge on clinical and epizootiologic 
features of protothecal mastitis are of the highest 
importance. In subclinical mastitis associated with 
increased SCC or mastitis that is irresponsive to 
antimicrobial therapy, timely suspicion of an algal 
infection is of crucial importance. Excessive empirical 
use of antibiotics should be avoided whenever possible, 
only in incident cases when apparent clinical 
manifestations require prompt intervention. Ideally, the 
therapy should be based on the results of laboratory 
identification of the causal agent of mastitis and the 
susceptibility of isolated bacterial species to antibiotics. 
In the case of protothecal or Candida mastitis the 
administration of antibiotics is useless, even 
counterproductive, and can be considered a misuse. 
Diagnosis of protothecal mastitis in a herd is 
considered a serious problem, especially in cases of late 
diagnosis, i.e. disseminated infection within the herd. 
Reduced milk production, increased SCC, lack of 
effective treatment, and unavoidable culling of infected 
cows from the herd can result in enormous health and 
economic losses. Control of the infection is a highly 
demanding procedure because of the high prevalence of 
the agent in the environment and spreading of the 
infection within the herd via milking equipment. So far, 
elimination of infected animals is necessary and is 
known to be the most effective method for disease 
control. Some recent attempts aiming at prevention and 
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control of protothecal mastitis are focused on 
immunodominant proteins of P. zopfii and potential 
immunisation based on recombinant proteins (12).  
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